The function of this Shared Resource is to provide an efficient, economical and effective use of animals for the performance of cancer-related studies. A significant emphasis is placed on the use of immunocompromised rodents. Major services provided by the Animal Research Resource include: animal purchase requests; inoculation of animals; propagation of tumor cell lines in animals; measurement of tumors; administration of carcinogens, s and hormonal agents; and necropsy. A service for the production of rabbit polyclonal antisera is also provided. Two additional rooms are also maintained to NIH Biosafety Level II standards for investigators using retroviral vectors and chemical carcinogens. Small transgenic breeding colonies are also maintained and a new transgenic Service has been established within the Resource, co-directed by Drs. Clarke and Dickson. The Shared resource is located within the Georgetown University Medical Center Research Resources Facility (RR). The is a centralized, AAALAC accredited and USDA registered research facility. All cell lines for inoculation require evidence of current murine antibody production test status. The general environment and animal health is monitored by the use of sentinel mice maintained in each colony room. All immunocompromised rodents are maintained within a viral antibody free environment. The services of this Resource are critical to the effective and economical use of animals by LCC investigators. The highly trained and experienced technical staff work closely with Cancer Center members to provide quality animal care and technical services in support of peer reviewed projects requiring the use of animals. Continuing increases in demand has required an increase in space to maintain rodents. We anticipate a further 50 percent increase in usage over the next five year period. The space requirements will be met with an ongoing RRF expansion. In 1995, the Shared Resource was utilized by 24 cancer center members m eight programs. 96 % of the projects utilizing the Shared Resource were supported by peer

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA051008-09
Application #
6102584
Study Section
Project Start
1998-05-15
Project End
1999-04-30
Budget Start
Budget End
Support Year
9
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lee, Yichien; Rodriguez, Olga C; Albanese, Chris et al. (2018) Divergent brain changes in two audiogenic rat strains: A voxel-based morphometry and diffusion tensor imaging comparison of the genetically epilepsy prone rat (GEPR-3) and the Wistar Audiogenic Rat (WAR). Neurobiol Dis 111:80-90
Coia, Heidi; Ma, Ning; Hou, Yanqi et al. (2018) Prevention of Lipid Peroxidation-derived Cyclic DNA Adduct and Mutation in High-Fat Diet-induced Hepatocarcinogenesis by Theaphenon E. Cancer Prev Res (Phila) 11:665-676
Ory, Virginie; Kietzman, William B; Boeckelman, Jacob et al. (2018) The PPAR? agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ. Breast Cancer Res Treat 169:47-57
Ozawa, Patricia Midori Murobushi; Alkhilaiwi, Faris; Cavalli, Iglenir João et al. (2018) Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells. Breast Cancer Res Treat 172:713-723
Smith, Jill P; Wang, Shangzi; Nadella, Sandeep et al. (2018) Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice. Cancer Immunol Immunother 67:195-207
Edwardson, Matthew A; Zhong, Xiaogang; Fiandaca, Massimo S et al. (2018) Plasma microRNA markers of upper limb recovery following human stroke. Sci Rep 8:12558
Kaat, Aaron J; Schalet, Benjamin D; Rutsohn, Joshua et al. (2018) Physical function metric over measure: An illustration with the Patient-Reported Outcomes Measurement Information System (PROMIS) and the Functional Assessment of Cancer Therapy (FACT). Cancer 124:153-160
Maximov, Philipp Y; Abderrahman, Balkees; Fanning, Sean W et al. (2018) Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer. Mol Pharmacol 94:812-822
Czarnecka, Magdalena; Lu, Congyi; Pons, Jennifer et al. (2018) Neuropeptide Y receptor interactions regulate its mitogenic activity. Neuropeptides :
Gonzalez, Thomas L; Moos, Rebecca K; Gersch, Christina L et al. (2018) Metabolites of n-Butylparaben and iso-Butylparaben Exhibit Estrogenic Properties in MCF-7 and T47D Human Breast Cancer Cell Lines. Toxicol Sci 164:50-59

Showing the most recent 10 out of 1120 publications